MedTrace Logo

Efficacy and Safety of Pediatric Drugs in Nasal Congestion

NCT02601235 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 292

Last updated 2019-10-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of the Naridrin in improving nasal congestion.

Conditions

  • Nasal Congestion

Interventions

DRUG

Naridrin

Naridrin® : 2 drops in each nostril once daily as prescription

DRUG

Afrin

2 pumps in each nostril every 12 hours.

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-16
Primary Completion
2018-08-03
Completion
2019-04-03

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02601235 on ClinicalTrials.gov